Bylined Guest Placements for Health and Food Brands

Roughly seven of every ten sites that arrive on a bought outreach list fail our editorial check before anyone pitches them: no named editor, no corrections policy, a sponsored section that has already run a supplement advertorial making a disease claim. We place bylined articles on what survives, and the byline belongs to a person on your side who can defend every sentence in it. Your RD, your PharmD, a food scientist, a clinician with a public profile and a licence number. What we place: A single-author article on a site with a real editorial staff, on a subject that person is genuinely qualified to write about. The link back sits in the body and points at the page that supports the claim being made: a protocol page, a clinical evidence summary, an ingredient dossier. Author bio links are not the point of the exercise and we do not count them as placements. Why the named author is not decoration: An editor at a health title with a medical reviewer will ask who wrote this and what their credential is. That question ends most guest posting programmes, because the honest answer is a freelancer with a stock headshot. When the answer is your director of clinical affairs, the conversation changes, and so does the class of publication willing to take the piece. It also means the draft can go through your own MLR or regulatory review before it leaves the building, which is the only version of this work a pharma or medtech client can use at all. What disqualifies a site for us: A write-for-us page that quotes a price. A sponsored subfolder that reads as inventory. A generic staff byline with no author pages behind it. Health sites running programmatic supplement affiliate content beside editorial. And any site hosting third-party subfolders or subdomains for unrelated commercial clients, which Google's site reputation abuse policy has been enforced against since November 2024. A link from that section is a liability with a date on it. Not included: We do not pay publications. If a title requires a fee, that is a sponsored placement, it carries rel=sponsored, and it belongs in a different engagement. No exact-match anchor text on a claim term, ever, in any vertical we work in. No monthly volume commitment. You get told what was placed and what was refused, and the refusals are written up with the reason, because that is the part that tells you where your positioning is weak. Who this is wrong for: Brands with no credentialed person in-house and no intention of appointing one. Supplement companies whose product claims will not survive an editor's check against the FTC's health products compliance guidance. Anyone who has to report a fixed number of links upward each month. That number does not exist here, and it is better that you know it before signing than after. How it runs: We agree the two or three subjects your named author can speak to that are also underserved in current coverage. We build the target list ourselves from editorial mastheads and journalist sources rather than a marketplace inventory. We pitch the idea before writing the draft, because a commissioned piece gets edited, promoted and kept, while an unsolicited one gets published and forgotten. Drafting sits with us, your author reviews and signs, and nothing goes out over a name that has not read it. Each placement comes back with the editor's name, the publication date, the rel attributes on the link as rendered, and the passage the link was placed to support.